Location: | Canary Wharf, London, Hybrid |
---|---|
Salary: | £76,000 |
Hours: | Full Time |
Contract Type: | Permanent |
Placed On: | 23rd June 2025 |
---|---|
Closes: | 13th July 2025 |
The MHRA is transforming. Through enabling innovation, making the right judgements of the benefits and risks of medical products and forging the right partnerships in the UK and internationally, it aims to deliver world class regulation and improved outcomes for UK patients.
We are currently looking for an experienced Head of Biosafety to join our Benefit Risk Evaluation I team in the Safety and Surveillance group.
Within a week of working here, your day could look like this: leading the integration of scientific, clinical, and technical expertise to deliver high-quality benefit-risk assessments and ensure effective matrix working across the Benefit-Risk Evaluation functions, the wider Safety and Surveillance Group, and Agency lifecycle group. The role is pivotal in ensuring timely and robust responses to potential safety concerns, directly informing evidence-based regulatory decisions that uphold public health and product performance standards.
The successful candidate will have experience in pre-clinical assessment, toxicology, genomics or diagnostics. They must also have experience of working at a senior level, communicating effectively with a range of senior level stakeholders.
Closing date: 13 July 2025
Type / Role:
Subject Area(s):
Location(s):